PROBLEMS FACED IN CONDUCTING CLINICAL TRIALS OF DRUGS IN PMS

Journal Title: International Journal of Medical and Clinical Research - Year 2011, Vol 2, Issue 2

Abstract

Introduction: Premenstrual syndrome is a psychoneuroendocrine disorder of unknown etiology. Even after > 80 years of its 1st description, its definition, presenting patterns , diagnostic plan and treatment modalities are surrounded by many questions and controversies. This results in a large number of studies with different criteria’s and methodologies so that their results are not comparable. Objective : To descries variability in opinions about PMS and highlight problems encountered in designing and conduct of clinical trials of various drugs in premenstrual syndrome. Method : The literature available in journals since inception of the term Premenstrual syndrome was reviewed. Variability in opinions of different workers regarding definition of PMS, days of premenstruum, diagnostic parameters was recorded and analysed. The methodological constraints in clinical trials of PMS due to lack of consensus among workers are mentioned and some corrective measures are suggested. Results : There is no consensus among workers regarding different aspects of premenstrual syndrome resulting in difficulties in designing and conduct of clinical trials in PMS. Conclusion : The authorities and organizations involved in research on PMS must frame standard guidelines for acceptable criteria and trial designs. So that comparative study of different trials becomes possible. Large multicentric trials in identical groups of population at same period of time by uniformly trained investigators are another alternative. Further research to elucidate exact etiopathogenesis and treatment guidelines is essential.

Authors and Affiliations

J. K. BAJAJ, S. J. SINGH, P. P. KHOSLA

Keywords

Related Articles

QUANTITATIVE REAL-TIME PCR ASSAY FOR DIFFERENTIATION BETWEEN PNEUMOCYSTIS PNEUMONIA AND PNEUMOCYSTISCOLONIZATION

Pneumocystis jirovecii is a life threatening opportunistic pathogen among immunocompromised individuals. In the present study we evaluated the applicability of quantitative PCR (qPCR) assays for differentiation among dis...

A STUDY OF PREVALENCE OF ORAL PRECANCEROUS LESIONS IN RELATION TO TOBACCO HABITUATION

Background: Oral cancer is a becoming leading global cause of morbidity and mortality. It is one of the ten most common cancers in the world. Oral cancer is almost all the time preceded by some type of precancerous lesio...

IMPLANT PLACEMENT IN ESTHETIC ZONE: A REAL CHALLENGING TASK

Implant placement and restoration to replace single or multiple teeth in the esthetic zone is an especially challenging area for the clinician, particularly in sites with deficiencies in soft tissue or bone. Preservation...

INCIDENCE OF VENTILATOR ASSOCIATED PNEUMONIA

Background: The development of VAP is also associated with greater hospital mortality rates and longer lengths of stay in Intensive Care Unit (ICU) and hospitals. A prospective study was conducted to find out the inciden...

PROTEINS OF CLASSICAL AND LECTIN PATHWAY OF THE COMPLEMENT SYSTEM INVOLVED IN THE PATHOGENESIS OF RHEUMATIC HEART DISEASE

Background: Rheumatic heart disease is an inflammatory disease which predominantly affects the valvular endocardium culminating in crippling valve deformities. Inorder to find out the role of complement proteins in induc...

Download PDF file
  • EP ID EP170026
  • DOI 10.9735/0976-5530.2.2.49-52
  • Views 115
  • Downloads 0

How To Cite

J. K. BAJAJ, S. J. SINGH, P. P. KHOSLA (2011). PROBLEMS FACED IN CONDUCTING CLINICAL TRIALS OF DRUGS IN PMS. International Journal of Medical and Clinical Research, 2(2), 49-52. https://www.europub.co.uk/articles/-A-170026